Active, Not Recruiting
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
NCT05060627
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hospital Germans Trias i Pujol (ICO BADALONA) Badalona, Spain
- Hospital Clinic Barcelona, Spain
- ICO Duran i Reynals L'Hospitalet de Llobregat, Spain
- H. Gregorio Marañón Madrid, Spain